Compare IMVT & BC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | BC |
|---|---|---|
| Founded | 2018 | 1845 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.8B |
| IPO Year | N/A | N/A |
| Metric | IMVT | BC |
|---|---|---|
| Price | $24.22 | $85.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $29.13 | ★ $77.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 02-06-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,362,800,000.00 |
| Revenue This Year | N/A | $8.82 |
| Revenue Next Year | N/A | $5.21 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.40 |
| 52 Week Low | $12.72 | $41.00 |
| 52 Week High | $27.80 | $89.61 |
| Indicator | IMVT | BC |
|---|---|---|
| Relative Strength Index (RSI) | 36.31 | 57.13 |
| Support Level | $25.42 | $78.15 |
| Resistance Level | $26.82 | $89.14 |
| Average True Range (ATR) | 1.11 | 2.76 |
| MACD | -0.27 | -0.48 |
| Stochastic Oscillator | 1.84 | 69.32 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns 440 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.